MedTrace Logo

Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1

NCT05277428 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2022-05-17

No results posted yet for this study

Summary

This study was conducted to investigate the effects of daily supplementation of L. plantarum APsulloc 331261(GTB1TM) on improvement of IBS symptoms.

Conditions

  • Irritable Bowel Syndrome With Diarrhea

Interventions

DIETARY_SUPPLEMENT

GTB1

2 capsule/day

DIETARY_SUPPLEMENT

Placebo

2 capsule/day

Sponsors & Collaborators

  • Amorepacific Corporation

    lead INDUSTRY

Principal Investigators

  • Jonghwa Roh, PhD · Amorepacific R&I center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2020-12-31
Completion
2022-01-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277428 on ClinicalTrials.gov